Noyes R D, Weiss S M, Krall J M, Sause W T, Owens J R, Wolkov H B, Lanciano R, Hanks G E, Hoffmann J
LDS Hospital, Salt Lake City, Utah.
J Surg Oncol. 1992 Aug;50(4):209-15. doi: 10.1002/jso.2930500402.
Intraoperative radiotherapy (IORT) is being used with increasing frequency in many institutions in the United States but little is known about the surgical complication rates. The Radiation Therapy Oncology Group initiated three prospective studies in IORT in 1986 and we report here the experience in advanced malignancies of the stomach, pancreas, and rectum. The incidence and nature of major surgical complications were reviewed and presented with their implications in regard to future IORT trials. Two hundred twenty-seven patients were entered on three studies by 20 participating institutions between 1985 and 1989. One hundred twenty-nine patients received IORT while 98 patients were found to have too advanced disease to be benefited by IORT and underwent palliative surgical procedures only. IORT doses ranged from 12-22 Gy and bowel anastomoses were not irradiated. Wound infection in the IORT group was 6% vs. 2% in the non-IORT patients but this was not significant at the P = 0.05 level. Other complications included anastomotic leak (n = 5), operative bleeding (n = 10), pancreatitis (n = 2), and were not statistically different in the IORT and non-IORT groups. The mortality rate for the IORT and non-IORT groups combined was 1.8%. This large multi-institutional experience in patients with advanced malignancy demonstrates that patients receiving IORT do not have a higher surgical complication rate than those not receiving IORT. Long-term survival data await the implementation of Phase III trials in advanced intra-abdominal malignancy.
术中放疗(IORT)在美国许多机构中的使用频率越来越高,但对于其手术并发症发生率却知之甚少。放射肿瘤学组于1986年启动了三项关于IORT的前瞻性研究,我们在此报告胃、胰腺和直肠晚期恶性肿瘤的研究经验。回顾了主要手术并发症的发生率和性质,并阐述了它们对未来IORT试验的影响。1985年至1989年间,20个参与机构的227名患者参与了三项研究。129名患者接受了IORT,而98名患者被发现疾病过于晚期,无法从IORT中获益,仅接受了姑息性手术。IORT剂量范围为12 - 22 Gy,未对肠吻合口进行照射。IORT组的伤口感染率为6%,而非IORT患者为2%,但在P = 0.05水平上无显著差异。其他并发症包括吻合口漏(n = 5)、手术出血(n = 10)、胰腺炎(n = 2),在IORT组和非IORT组中无统计学差异。IORT组和非IORT组合并后的死亡率为1.8%。这项针对晚期恶性肿瘤患者的大型多机构研究经验表明,接受IORT的患者手术并发症发生率并不高于未接受IORT的患者。长期生存数据有待晚期腹腔内恶性肿瘤III期试验的实施。